Back
Zealand Pharma AS Quote, Financials, Valuation and Earnings
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
45
ZLDPF
Zealand Pharma AS
Last Price:
114.49
Seasonality Move:
6.5%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Zealand Pharma AS Price Quote
$114.49
+8.49 (+8.01%)
(Updated: December 12, 2024 at 5:55 PM ET)
Zealand Pharma AS Key Stats
Sell
45
Zealand Pharma AS (ZLDPF)
is a Sell
Day range:
$106.00 - $106.00
52-week range:
$47.93 - $141.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
603.31
P/B ratio:
5.63%
Volume:
0
Avg. volume:
2.1K
1-year change:
121.2%
Market cap:
$7.5B
Revenue:
$49.8M
EPS:
$-2.43
How Much Does Zealand Pharma AS Make?
-
How Much Are Zealand Pharma AS's Sales Annually?
ZLDPF Revenues are $49.8M -
How Much Profit Does Zealand Pharma AS's Make A Year?
ZLDPF net income is -$102.2M
Is Zealand Pharma AS Growing As A Company?
-
What Is Zealand Pharma AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.98% -
What Is Zealand Pharma AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Zealand Pharma AS Stock Price Performance
-
Did Zealand Pharma AS Stock Go Up Last Month?
Zealand Pharma AS share price went down by -15.87% last month -
Did ZLDPF's Share Price Rise Over The Last Year?
ZLDPF share price rose by 121.2% over the past 1 year
What Is Zealand Pharma AS 52-Week High & Low?
-
What Is Zealand Pharma AS’s 52-Week High Share Price?
Zealand Pharma AS has traded as high as $141.74 over the past 52 weeks -
What Is Zealand Pharma AS’s 52-Week Low Share Price?
Zealand Pharma AS has traded as low as $47.93 over the past 52 weeks
Zealand Pharma AS Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Zealand Pharma AS?
-
How Much Debt Does Zealand Pharma AS Have?
Total long term debt quarterly is $42.1M -
How Much Cash Does Zealand Pharma AS Have?
Cash and short term investments quarterly total is $1.3B -
What Is Zealand Pharma AS’s Book Value Per Share?
Book value per share is 18.83
Is Zealand Pharma AS Cash Flow Positive?
-
What Is ZLDPF Cash Flow From Operations?
Cash flow from operations (TTM) is -$101.5M -
What Is Zealand Pharma AS’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2B -
What Is Zealand Pharma AS’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1.1B
Zealand Pharma AS Return On Invested Capital
-
Is Management Doing A Good Job?
ZLDPF return on invested capital is -20.65% -
What Is Zealand Pharma AS Return On Assets?
ROA measures how assets are converting to revenues and is -19.03% -
What Is ZLDPF Return On Equity?
ROE is a measure of profitability and is -21.35%
Zealand Pharma AS Earnings Date & Stock Price
-
What Is Zealand Pharma AS's Stock Price Today?
A single share of ZLDPF can be purchased today for 106.00 -
What Is Zealand Pharma AS’s Stock Symbol?
Zealand Pharma AS trades on the otcm under the ticker symbol: ZLDPF -
When Is Zealand Pharma AS’s Next Earnings Date?
The next quarterly earnings date for Zealand Pharma AS is scheduled on February 20, 2025 -
When Is ZLDPF's next ex-dividend date?
Zealand Pharma AS's next ex-dividend date is December 13, 2024 -
How To Buy Zealand Pharma AS Stock?
You can buy Zealand Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Zealand Pharma AS Competitors
-
Who Are Zealand Pharma AS's Competitors?
Below is a list of companies who compete with Zealand Pharma AS or are related in some way:
Zealand Pharma AS Dividend Yield
-
What Is ZLDPF Dividend Yield?
Zealand Pharma AS’s dividend yield currently is 0% -
What Is Zealand Pharma AS’s Payout Ratio?
Zealand Pharma AS’s payout ratio is 0% -
When Did Zealand Pharma AS Last Pay A Dividend?
The latest dividend pay date is December 13, 2024 -
What Is Zealand Pharma AS’s Dividend Per Share?
Zealand Pharma AS pays a dividend of $0.00 per share
Zealand Pharma AS Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -98.49% | -91.85% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 22.50 |
| Downside from Last Price: | -78.77% |